Clinical Trial Update: Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing an investigational yellow fever vaccine with Stamaril in adults in Europe and Asia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Yellow Fever

Drugs mentioned

• Investigational Yellow Fever Vaccine
• Stamaril (Yellow fever vaccine (live attenuated))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Yellow Fever | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-21